Fig. 2
From: A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
Distribution of adverse events associated with brodalumab by system organ class.
Fig. 2 | Scientific Reports
From: A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
Distribution of adverse events associated with brodalumab by system organ class.
